Home › Funds › BAKER BROS. ADVISORS LP › JBIO

BAKER BROS. ADVISORS LP position in JBIO

JADE BIOSCIENCES INC · Health Care

BAKER BROS. ADVISORS LP reported holding 1,230,426 shares of JBIO (JADE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$27.3M, representing 0.14% of its reported portfolio and ranking #46 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed JBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.23M sh
Reported value held$27.34M
Portfolio Weight0.14%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's JBIO position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in JBIO in Q4 2025 at 1,641,137 shares (US$25.3M). The position peaked in Q2 2026 at 1,230,426 shares, worth US$27.3M. Across 3 filings, BAKER BROS. ADVISORS LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,230,426 shares valued at US$27.3M — a reduction of -410,711 shares quarter over quarter.. Notable position changes include a 25% trim in Q2 2026 (shares fell 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.64M $25.32M New
Q1 2026 1.64M $23.06M Hold
Q2 2026 1.23M $27.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 106 other funds we track also report a position in JBIO — the largest reported positions include Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held JBIO?

BAKER BROS. ADVISORS LP has disclosed JBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is BAKER BROS. ADVISORS LP's current position in JBIO?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 1.23M shares of JBIO (JADE BIOSCIENCES INC), valued at $27.34M, representing 0.14% of its reported portfolio and ranking #46.

Has BAKER BROS. ADVISORS LP been buying or selling JBIO?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP reduced its position in JBIO. The position peaked in Q2 2026 at 1.23M shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.